HK1084588A1 - Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one - Google Patents

Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one

Info

Publication number
HK1084588A1
HK1084588A1 HK06104915A HK06104915A HK1084588A1 HK 1084588 A1 HK1084588 A1 HK 1084588A1 HK 06104915 A HK06104915 A HK 06104915A HK 06104915 A HK06104915 A HK 06104915A HK 1084588 A1 HK1084588 A1 HK 1084588A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pyrazolin
phenyl
methyl
precutaneous
Prior art date
Application number
HK06104915A
Other languages
English (en)
Inventor
Jun Mori
Horiuchi Tamaki
Yama Seijiro
Waki Hitomi
Shimada Shingo
Hashitani Hitomi
Original Assignee
Lead Chem Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Chem Co Ltd filed Critical Lead Chem Co Ltd
Publication of HK1084588A1 publication Critical patent/HK1084588A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK06104915A 2002-11-05 2006-04-25 Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one HK1084588A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/011518 WO2004041270A1 (ja) 2002-11-05 2002-11-05 ３−メチル−１−フェニル−２−ピラゾリン−５−オン含有経皮吸収製剤

Publications (1)

Publication Number Publication Date
HK1084588A1 true HK1084588A1 (en) 2006-08-04

Family

ID=32310225

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06104915A HK1084588A1 (en) 2002-11-05 2006-04-25 Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one

Country Status (10)

Country Link
US (1) US20050266062A1 (ja)
EP (1) EP1559426B1 (ja)
JP (1) JP4487258B2 (ja)
CN (1) CN100372531C (ja)
AT (1) ATE497764T1 (ja)
AU (1) AU2002344454A1 (ja)
CA (1) CA2504873C (ja)
DE (1) DE60239165D1 (ja)
HK (1) HK1084588A1 (ja)
WO (1) WO2004041270A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004307364A (ja) * 2003-04-03 2004-11-04 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
KR101008052B1 (ko) * 2003-11-12 2011-01-13 리도 케미칼 가부시키가이샤 경피흡수형 뇌 보호제
JP2006298774A (ja) * 2005-04-15 2006-11-02 Lead Chemical Co Ltd 経皮吸収型フリーラジカル抑制製剤
CN101184479B (zh) * 2005-06-01 2011-05-04 尼普洛外用药品株式会社 贴剂
CN100420726C (zh) * 2005-09-19 2008-09-24 上海安立霸电器有限公司 医用热熔压敏胶型基质及制备
JP4974535B2 (ja) * 2006-02-02 2012-07-11 久光製薬株式会社 外用製剤及びその製造方法
JP5248040B2 (ja) * 2007-05-25 2013-07-31 リードケミカル株式会社 ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤
WO2009041714A1 (ja) * 2007-09-26 2009-04-02 Mikasa Seiyaku Co., Ltd. フリーラジカル性疾患用外用剤
DE102011087317A1 (de) * 2011-11-29 2013-05-29 Henkel Ag & Co. Kgaa Kosmetische Verwendung von 3-Methyl-1-phenyl-5-pyrazolon
JP6444305B2 (ja) * 2013-08-09 2018-12-26 帝國製薬株式会社 ベラプロスト含有貼付剤
US9675537B2 (en) * 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
KR20210065931A (ko) * 2018-09-26 2021-06-04 니찌방 가부시기가이샤 함수계 첩부제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066533B2 (ja) * 1985-09-13 1994-01-26 日東電工株式会社 含水ゲル貼付剤の基剤
JP2512565B2 (ja) * 1989-10-13 1996-07-03 積水化学工業株式会社 貼付剤
JP2569396B2 (ja) * 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
ES2151464T3 (es) * 1996-02-07 2002-12-16 Lead Chem Co Ltd Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.
JPH10120560A (ja) * 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
JPH10265373A (ja) * 1997-03-26 1998-10-06 Lion Corp 粘着剤組成物及びパップ剤
JPH10279480A (ja) * 1997-04-07 1998-10-20 Mitsubishi Chem Corp 皮膚組織障害の予防・治療剤
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
WO2000064434A1 (fr) * 1999-04-26 2000-11-02 Lead Chemical Co., Ltd. Preparations percutanees contenant de l'oxybutynine
DE60138385D1 (de) * 2000-06-29 2009-05-28 Mei Co Ltd Heilmittel zur behandlung von erkrankungen des sehnervs

Also Published As

Publication number Publication date
US20050266062A1 (en) 2005-12-01
DE60239165D1 (de) 2011-03-24
JPWO2004041270A1 (ja) 2006-03-02
CA2504873C (en) 2011-04-26
CN1694699A (zh) 2005-11-09
CA2504873A1 (en) 2004-05-21
AU2002344454A1 (en) 2004-06-07
ATE497764T1 (de) 2011-02-15
CN100372531C (zh) 2008-03-05
WO2004041270A1 (ja) 2004-05-21
EP1559426A4 (en) 2009-03-11
JP4487258B2 (ja) 2010-06-23
EP1559426B1 (en) 2011-02-09
EP1559426A1 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
HK1084588A1 (en) Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
EP0974350A4 (en) EXTERNAL CONTAINING TRANILAST AND METHOD FOR THE PRODUCTION THEREOF
IL148384A0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
AU4438489A (en) Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
IL154231A0 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU4723197A (en) Tricyclic amine derivatives
EP1374868A4 (en) MEDICAMENT FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC ISCHEMIC DISEASES
ZA200105886B (en) Agent of treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient.
DE69930621D1 (de) Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung
EP1685837A4 (en) BRAIN PROTECTIVE AGENT OF THE TYPE ADMINISTERED BY PERCUTANEOUS ABSORPTION
AU1651201A (en) Amidinophenylpyruvic acid derivative
IL143873A0 (en) Dry skin remedies
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
AU2662300A (en) Cyclic guanidine derivatives and their use as pesticides
CA2244679A1 (en) Tranilast-containing preparation for external application and method of producing the same
EP1408043A8 (en) 2''oxo-voruscharin and analogues thereof

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20221104